3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Breast
1
Conditions
Motor Activity
197
Breast Neoplasms
112
Neoplasms
83
Fatigue
29
Prostatic Neoplasms
27
Lung Neoplasms
20
Colorectal Neoplasms
20
Obesity
19
Polycystic Ovary Syndrome
14
Ovarian Neoplasms
11
Colonic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Rectal Neoplasms
10
Pancreatic Neoplasms
10
Lymphedema
10
Multiple Myeloma
9
Lymphoma
9
Hematologic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Head and Neck Neoplasms
8
Cardiotoxicity
8
Weight Loss
7
Stomach Neoplasms
7
Peripheral Nervous System Diseases
6
Leukemia
6
Insulin Resistance
6
Esophageal Neoplasms
6
Brain Neoplasms
6
Sarcopenia
5
Endometrial Neoplasms
5
Interventions
Cyclophosphamide
16
fludarabine phosphate
13
Peripheral Blood Stem Cell Transplantation
13
Whole-Body Irradiation
10
Cyclosporine
10
Antilymphocyte Serum
9
Melphalan
8
Busulfan
8
Mycophenolic Acid
7
Filgrastim
6
fludarabine
5
Radiotherapy
5
Methotrexate
5
Etoposide
5
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cytarabine
4
Carmustine
4
Blood Specimen Collection
4
thymoglobulin
3
Therapeutics
3
Rituximab
3
Flow Cytometry
3
Aprepitant
3
Analgesia
3
Tacrolimus
2
Stem Cell Transplantation
2
Proton Therapy
2
Polymerase Chain Reaction
2
Ondansetron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hodgkin Disease
×
Exercise
×
Clear all
NCT05595577
2026-03-20
PALS
Wake Forest University Health Sciences
Phase NA
Recruiting
110 enrolled